Diffüz alopesili kadınlarda öfke, anksiyete ve depresyon

Objective: Present study aims to compare control group patients and patients with diffuse alopecia in order to understand the nature of the relationship between symptoms and level of anger and to see whether patient group has higher number of symptoms than control group. Methods: 43 female patients who were diagnosed diffuse alopecia in dermatology clinic and 52 age-andgender-matched control participants were included in the study. 20% of patients (n=19) with androgenetic alopecia, 10.5% of patients (n=10) with diffuse alopecia areata and 14.7% of patients (n=14) with telogen effluvium participated in study. Hospital Anxiety and Depression Scale (HADS) and The Trait Anger and Anger Expression Scale (TAAES) were filled by the participants. Also patients were followed up by a standard hospital form recording alopecia. Results: It was found that patients with alopecia revealed significantly more depression (p<0,001) and anxiety (p<0,001) scores than control group. Also trait anger (β = 0,216, Wald Z = 3,697, Exp(B)= 1,241, p<0,05) and anxiety (β = -0.466, Wald Z = 5,008, Exp(B)= 0.628, p<0,05) scores significantly predicted alopecia group. Additionally total time period for alopecia significantly and positively correlated with depression (r= 0,402, p<0.01) and anxiety (r=0,393, p<0,01) scores. Comparing patient groups with each other, trait anger and expressed anger were significantly different across groups. Conclusion: Patient group reported more anxiety and depressive symptoms than control group. In treatment of patients with alopecia, bidirectional relationship between alopecia and psychological symptoms should be in consideration. Collaboration with psychiatry is suggested in order to improve treatment efficacy and patients’ life satisfaction. In addition anger management seems essential in treatment of patients with diffuse alopecia